ZSAN

Zosano Pharma (ZSAN)

Zosano Pharma Corporation

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:ZSAN

<< 이전 1 2 3 4 5 6 7 8 9 10 11 12 13 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2020/10/21	21:30	GlobeNewswire Inc.	Zosano Pharma Receives Complete Response Letter from FDA for Qtrypta™	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/10/01	06:40	GlobeNewswire Inc.	Zosano Pharma Receives Preliminary FDA Communication on Qtrypta™ NDA	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/10/01	06:26	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/09/09	21:30	GlobeNewswire Inc.	Zosano Pharma to Present at the Cantor Virtual Global Healthcare Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/09/03	21:00	GlobeNewswire Inc.	Zosano Pharma to Present at the H.C. Wainwright Annual Global Investment Conference	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/09/02	06:23	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/09/01	22:00	GlobeNewswire Inc.	Zosano Announces Pricing of Public Offering of Common Stock	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/09/01	05:05	GlobeNewswire Inc.	Zosano Pharma Announces Proposed Public Offering of Common Stock	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/18	21:30	GlobeNewswire Inc.	Zosano Pharma Announces Agreement to Collaborate with Mitsubishi Tanabe Pharma Corporation	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/18	05:20	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/12	05:13	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/07	06:00	GlobeNewswire Inc.	Zosano Pharma Announces Partnership Agreement with EVERSANA to Support the Launch and Commercialization of Qtrypta™	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/07	05:54	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/06	21:21	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/06	21:00	GlobeNewswire Inc.	Zosano Pharma Reports Second Quarter 2020 Financial Results and Provides Corporate Update	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/08/04	05:05	GlobeNewswire Inc.	Zosano Pharma to Present at the BTIG Biotechnology Conference 2020	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:25	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:22	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:19	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:18	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:17	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/30	22:13	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/15	21:27	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/13	19:00	GlobeNewswire Inc.	Zosano Pharma to showcase new post-hoc analyses of Qtrypta’s (M207) clinical trial data comparing key efficacy results from...	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/12	05:34	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/12	05:26	Edgar (US Regulatory)	Securities Registration: Employee Benefit Plan (s-8)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/09	06:19	Edgar (US Regulatory)	Current Report Filing (8-k)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/09	06:14	Edgar (US Regulatory)	Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)	NASDAQ:ZSAN	Zosano Pharma Corporation
2020/06/06	07:43	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	NASDAQ:ZSAN	Zosano Pharma Corporation